US doc warned not to market three-parent baby technique
A New York fertility doctor has been slapped down by the US Food and Drug Administration (FDA) for marketing a controversial three-parent baby technique.
A New York fertility doctor has been slapped down by the US Food and Drug Administration (FDA) for marketing a controversial three-parent baby technique.
An embryo editing ‘breakthrough’ is ethically dubious and could have irreversible results if given legal approval, a leading fertility expert has warned.